EYE » Topics » Directors Continuing in Office - Term Expiring 2007
This excerpt taken from the EYE DEF 14A filed Apr 20, 2006.
Continuing in Office Term Expiring 2007
William R. Grant Class II
Director since October 2001
Audit and Finance; Organization, Compensation and Corporate Governance
Mr. Grant is the Chairman of the Board of
Directors, a position he has held since January 2002. He is a co-founder
of Galen Associates, Inc., a venture capital firm in the health care
industry, and has been its Vice Chairman since April 2005. He was
Chairman of Galen Associates from 1989 to April 2005. Mr. Grant has
50 years of experience in the investment banking and risk-capital fields,
including substantial experience in the health care industry. He was
President of Smith Barney Inc., Chairman of MacKay-Shields Financial
Corporation and is a former director of Ocular Sciences, Inc.,
Allergan, Inc., Coldwell Banker, New York Life Inc., Witco Corporation
and Fluor Corporation. Currently Mr. Grant is also a director of Vasogen
Inc. (Chairman), Quest Diagnostics Incorporated and Massey Energy Company.
Christopher G. Chavez Class II
Director since June 2002
Organization, Compensation and Corporate Governance; Science and Technology
Mr. Chavez is
President of Advanced Neuromodulation Systems (ANS), a position he has held
since he joined ANS in April 1998 and which he continues to hold
following the acquisition of ANS by St. Jude Medical, Inc. in
November 2005. From April 1998 to November 2005,
Mr. Chavez was also Chief Executive Officer and a Director of ANS. Prior
to joining ANS, Mr. Chavez was Vice President of Worldwide Marketing and
Strategic Planning for Eastman Kodaks Health Imaging Division where the
divisions five worldwide profit centers reported to him. From 1981 to 1997,
Mr. Chavez was with Johnson & Johnson Medical, Inc., a
major division of Johnson & Johnson. While with J&J, he
progressed through several positions in finance, strategic planning, domestic
and international marketing, new business development and general management.
His most recent position was Vice President and General Manager of the
Infection Prevention Business Unit, one of four worldwide business units with
approximately one-half billion dollars in sales. Mr. Chavez currently
serves on the Board of Directors of the Medical Device Manufacturers
Elizabeth H. Dávila Class II
Director since May 2005
Science and Technology
Ms. Dávila is a
retired executive and the former Chairman of the Board of Directors and Chief
Executive Officer of VISX, Incorporated, which Advanced Medical Optics
acquired by merger in May 2005. Ms. Dávila served on the VISX Board
of Directors from 1995 to 2005, and served as its Chairman and Chief
Executive Officer from 2001 to 2005. From 1995 to 2001, Ms. Dávila held
a number of positions at VISX, including Executive Vice President, President,
and Chief Operating Officer. Prior to joining VISX, Ms. Dávila was at
Syntex Corporation from 1977 to 1994, where she held senior management positions
in its medical device, medical diagnostics, and pharmaceutical divisions.
Ms. Dávila serves on the Board of Directors of Cholestech Corporation.
She holds a masters degree in Chemistry from the University of Notre Dame and
an M.B.A. from Stanford University.
Bet you've never seen portfolio analytics like these.